- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Current flows with $220m series D round
The CMFG Ventures-backed challenger bank’s latest round valued it at $2.2bn and pushed its total funding past $400m.
Apr 28, 2021Exscientia checks off $225m series D
The artificial intelligence drug developer has closed a $225m round led by SoftBank Vision Fund 2, which has offered a further $300m in funding.
Apr 28, 2021Dentsu dedicates capital to second fund
The marketing group’s $92.2m vehicle is set to operate for 10 years and strengthen its presence in the Japanese startup ecosystem.
Apr 28, 2021Koch assists Automox in $110m series C
Koch Disruptive Technologies returned to reinvest in the endpoint cybersecurity software provider, helping boost its overall funding to more than $152m.
Apr 28, 2021Lynch and Skoberne enlist in GV
Alphabet early-stage investment unit GV has added two biotechnology professionals, Dan Lynch and Mojca Skoberne, to its team.
Apr 28, 2021OcuTerra orchestrates series B
Allied Minds portfolio company OcuTerra Therapeutics has secured $14.6m in funding.
Apr 28, 2021Saint-Gobain gravitates to Richland Capital
Saint-Gobain has contributed to Richland Capital’s third fund, which had already attracted Tsinghua Asset Management’s Redbud vehicle.
Apr 28, 2021Main Sequence burns bright with $194m
CSIRO-founded Main Sequence Ventures has pocketed $194m for its second fund, which has added decarbonisation to the firm’s list of targeted technologies.
Apr 28, 2021Exscientia erects $225m series D
Less than two months after closing a $100m series C round, the Dundee spinout has raised $225m in a series D led by SoftBank Vision Fund 2.
Apr 28, 2021Lockheed Martin finds Main Sequence for $194m fund
Lockheed Martin has returned to invest in Main Sequence Ventures’ second fundraise having previously committed to its Csiro-mandated first fund.
Apr 28, 2021Scivita Medical selects corporates for series A
Lilly Asia Ventures co-led a $61.7m round for the endoscopy technology developer that was also backed by Medtronic.
Apr 28, 2021Saint-Gobain gravitates to Richland Capital
Saint-Gobain has contributed to Richland Capital’s third fund, joining fellow corporate investors Asahi Kasei and Solvay.
Apr 28, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
